Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × pertuzumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 141 HER2-positive Breast Cancer 15 Neoplasms 11 Neoplasm Metastasis 8 Carcinoma, Non-Small-Cell Lung 6 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Stomach Neoplasms 4 Inflammatory Breast Neoplasms 4 Colonic Neoplasms 4 Brain Neoplasms 4 Triple Negative Breast Neoplasms 3 Solid Tumor 3 Pathologic Complete Response 3 Pancreatic Neoplasms 3 Multiple Myeloma 3 Lymphoma, Non-Hodgkin 3 Endometrial Neoplasms 3 Breast Neoplasms, Male 3 Biliary Tract Neoplasms 3 Anatomic Stage I Breast Cancer AJCC v8 3 Rectal Neoplasms 2 Locally Advanced Breast Cancer 2 Hematologic Neoplasms 2 HER2-positive Metastatic Breast Cancer 2 HER2-positive Early Breast Cancer 2 Gastrointestinal Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Ductal, Breast 2 Anatomic Stage II Breast Cancer AJCC v8 2

Interventions

Echocardiography 4 Standard of Care 3 Exercise 3 Electrocardiography 3 sacubitril and valsartan sodium hydrate drug combination 2 Surveys and Questionnaires 2 Spironolactone 2 Rituximab 2 Nutrition Assessment 2 Lenalidomide 2 Ivabradine 2 Control Groups 2 Carvedilol 2 Blood Specimen Collection 2 Atorvastatin 2 Adrenergic beta-Antagonists 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 dapagliflozin 1 candesartan 1 acalabrutinib 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04680442 2025-04-06

SCHOLAR-2

Population Health Research Institute

Phase 2 Recruiting

Breast Neoplasms, Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡